27822-59-9

Basic information

• Product Name: Carbamic acid, (1-methyl-2-phenylethyl)-, ethyl ester
• CAS NO: 27822-59-9
• Molecular Formula: C12H17NO2
• Molecular Weight: 207.272
• Mol File: 27822-59-9.mol

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (1-methyl-2-phenylethyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (1-methyl-2-phenylethyl)-, ethyl ester(27822-59-9)
• EPA Substance Registry System: Carbamic acid, (1-methyl-2-phenylethyl)-, ethyl ester(27822-59-9)

Safety Data

• Hazardous Substances Data: 27822-59-9(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 58321-79-2 (Z)-(2-nitroprop-2-en-1-yl)benzene 
• 75-00-3 chloroethane 
• 124-38-9 carbon dioxide 
• 60-15-1 2-amino-1-phenylpropane 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 7632-10-2 methamphetamin 

Relevant articles and documents

Determination of the synthetic origin of methamphetamine samples by 2H NMR spectroscopy

Samples of methamphetamine, prepared according to the most common synthetic pathways, were submitted to natural-abundance 2H NMR spectroscopy. The deuterium content at the various sites of the molecule was found to depend on its synthetic history. The technique provides a chemical fingerprint of methamphetamine samples and can give hints to trace back the starting materials and the synthetic procedures.

Asymmetric organic synthesis. Preparation and Birch reduction-alkylation of 2-methyl-3,4-dihydroisoquinolin-1-ones

Birch reductions of 2-methyl-3,4-dihydroisoquinolin-1-ones 1 and 6 generate enolates 2a and 2b and alkylations provide 1,4-cyclohexadienes 3a-3e and 7a-7c. The synthesis of a racemic structural analogue, 9, of the potent analgetic levorphanol is described.

1-Ethoxy-3,4-dihydroisoquindines

1-(2-Substituted-hydrazino)-3,4-dihydroisoquinolines, prepared in one process by alkylating the corresponding 3,4-dihydroisocarbostyrils, hydrazinolyzing the resulting 1-alkoxy-3,4-dihydroisoquinolines and condensing the resulting 1-hydrazIno-3,4-dihydroisoquinolines with aldehydes or ketones, and 1,1'-azinobis(1,2,3,4-tetrahydroisoquinolines), prepared by condensing corresponding 1-alkoxy-3,4-dihydroisoquinolines and 1-hydrazino-3,4-dihydroisoquinolines, are useful as antihypertensive agents and/or as antiinflammatory agents.